Maintenance of the EBV-specific CD8+ TCRαβ repertoire in immunosuppressed lung transplant recipients
Autor: | Paul G. Thomas, Nicole A. Mifsud, Tom Kotsimbos, Thi H. O. Nguyen, Katherine Kedzierska, Nicola L. Bird, John J. Miles, Emma J. Grant |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Epstein-Barr Virus Infections Herpesvirus 4 Human medicine.medical_treatment T cell Receptors Antigen T-Cell alpha-beta Immunology Viremia Biology CD8-Positive T-Lymphocytes 03 medical and health sciences Immune system Antigen medicine Immunology and Allergy Humans Amino Acid Sequence Epstein–Barr virus infection Immunosuppression Therapy T-cell receptor Immunosuppression Cell Biology medicine.disease Allografts Virology Tissue Donors Transplant Recipients 3. Good health 030104 developmental biology medicine.anatomical_structure DNA Viral Original Article Virus Activation Peptides CD8 Lung Transplantation |
Zdroj: | Immunology and Cell Biology |
ISSN: | 1440-1711 0818-9641 |
Popis: | Epstein-Barr virus (EBV) is one of the most common viruses in humans, capable of causing life-threatening infections and cancers in immunocompromised individuals. Although CD8+ T cells provide key protection against EBV, the persistence and dynamics of specific T-cell receptor (TCR) clones during immunosuppression in transplant patients is largely unknown. For the first time, we used a novel single-cell TCRαβ multiplex-nested reverse transcriptase PCR to dissect TCRαβ clonal diversity within GLCTLVAML (GLC)-specific CD8+ T cells in healthy individuals and immunocompromised lung transplant recipients. The GLC peptide presented by HLA-A*02:01 is one of the most immunogenic T-cell targets from the EBV proteome. We found that the GLC-specific TCRαβ repertoire was heavily biased toward TRAV5 and encompassed five classes of public TCRαβs, suggesting that these clonotypes are preferentially utilized following infection. We identified that a common TRAV5 was diversely paired with different TRAJ and TRBV/TRBJ genes, in both immunocompetent and immunocompromised individuals, with an average of 12 different TCRαβ clonotypes/donor. Moreover, pre-transplant GLC-specific TCRαβ repertoires were relatively stable over 1 year post transplant under immunosuppression in the absence or presence of EBV reactivation. In addition, we provide the first evidence of early GLC-specific CD8+ T cells at 87 days post transplant, which preceded clinical EBV detection at 242 days in an EBV-seronegative patient receiving a lung allograft from an EBV-seropositive donor. This was associated with a relatively stable TCRαβ repertoire after CD8+ T-cell expansion. Our findings provide insights into the composition and temporal dynamics of the EBV-specific TCRαβ repertoire in immunocompromised transplant patients and suggest that the early detection of EBV-specific T cells might be a predictor of ensuing EBV blood viremia. |
Databáze: | OpenAIRE |
Externí odkaz: |